Delisting acquisition offer to the shareholders of STADA Arzneimittel AG

Details of Nidda Healthcare Holding AG's delisting acquisition offer to the shareholders of STADA Arzneimittel AG registered shares (ISIN DE0007251803) are described in the following.

Exchange into "STADA Arzneimittel AG registered shares submitted for sale"

The transfer will take place via a securities transfer (CASCADE-Transaction: KVEE WE) by indicating "4 – Originalaktien in Anrechte" in the "TR" field. This transfer is only possible from the unregistered positions (FMB). The shares must therefore be transferred in advance via a position transfer (CASCADE-RS transaction: KVEE BV) into the unregistered positions.

The exchange will be possible from

11 October 2018 to 8 November 2018 inclusive

The "STADA Arzneimittel AG registered submitted for sale" (ISIN DE000A2NBUK2) will be issued as registered securities. The certificates resulting from the exchange described above will be allocated to the unregistered positions.

There is a follow-up transfer period up to 12 November 2018.

Registration of shareholders via re-registration

The shareholders of the "STADA Arzneimittel AG registered shares subsequently submitted for sale" (ISIN DE000A2NBUK2) must be recorded in the company's share register. Corresponding re-registrations (KVCU) may be performed by the depository banks in CASCADE-RS starting 11 October 2018.

Information on submission planning

Due to the processing capacities in CASCADE-RS, submissions amounting to 10,000 re-registrations or more per transfer must be arranged in advance with Client Services. Within the scope of overall coordination, Clearstream Banking¹ reserves the right to reject file transfers that have not been arranged in advance.

------------------------------------------

1. This Announcement is published by Clearstream Banking AG (CBF), registered office at Mergenthalerallee 61, 65760 Eschborn, Germany, registered with the Commercial Register of the District Court in Frankfurt am Main, Germany, under number HRB 7500.